MedTrace Logo

Positron Emission Mammography and Standard Mammography in Women at High Risk of Breast Cancer

NCT00896649 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 193

Last updated 2017-05-09

Study results available
· View outcomes & findings →

Summary

RATIONALE: Screening tests may help doctors find cancer cells early and plan better treatment for breast cancer. It is not yet known whether positron emission mammography is more effective than standard mammography in finding breast tumors.

PURPOSE: This phase III trial is studying positron emission mammography to see how well it works compared with standard mammography in women undergoing screening mammogram at Boston Medical Center.

Conditions

Interventions

OTHER

questionnaire administration

Questionnaire regarding patient satisfaction with mammogram experience and with positron emission mammography experience.

PROCEDURE

digital mammography

standard screening mammogram

PROCEDURE

positron emission mammography

one-time positron emission mammography to compare recall rates with that of standard mammogram

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Gustavo Mercier, MD, PhD · Boston Medical Center

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2012-07-31
Completion
2017-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00896649 on ClinicalTrials.gov